Mark Mirochnick

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial”.

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet(2021)10.1016/s0140-6736(21)00314-7

N/A

5.5DataRank · unranked

162 citations

Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti +39 more

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

The Lancet HIV(2020)10.1016/s2352-3018(20)30038-2

N/A

1.7DataRank · unranked

46 citations

R. L. Morrison, David E. Shapiro, Nahida Chakhtoura, Maria Isabel S. Gouvea, Maria de Lourdes Benamor Teixeira +23 more

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00061-9

N/A

1.1DataRank · unranked

30 citations

Lauren Ziemba, Sean S. Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje +95 more

Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study

The Lancet HIV(2020)10.1016/s2352-3018(20)30274-5

N/A

0.874DataRank · unranked

19 citations

Edmund V. Capparelli, Camlin Tierney, Bryan S Nelson, Anne Coletti, Yvonne J. Bryson +13 more

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.02168-20

N/A

0.761DataRank · unranked

20 citations

Kensuke Shoji, Brookie M. Best, Jeremiah D. Momper, Alice Stek, Tim R. Cressey +3 more

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study

The Lancet HIV(2023)10.1016/s2352-3018(23)00236-9

N/A

0.760DataRank · unranked

23 citations

Yvonne J. Bryson, Bryan S Nelson, Camlin Tierney, Mark F. Cotton, Anne Coletti +17 more

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

BMC Infectious Diseases(2022)10.1186/s12879-022-07608-8

N/A

0.378DataRank · unranked

5 citations

Bonus Makanani, Camlin Tierney, Mary Glenn Fowler, Dhayendre Moodley, Gerhard Theron +76 more

Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae298

N/A

0.340DataRank · unranked

6 citations

Kristin Baltrusaitis, Diana F. Clarke, Sharon Nachman, Jennifer Jao, Murli Purswani +56 more

Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy

Clinical Infectious Diseases(2024)10.1093/cid/ciae441

N/A

0.165DataRank · unranked

2 citations

Sean S. Brummel, Muktar H. Aliyu, Lynda Stranix‐Chibanda, George Uchenna Eleje, Ifeanyichukwu U. Ezebialu +56 more

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

PLoS ONE(2022)10.1371/journal.pone.0275254

N/A

0DataRank · unranked

2 citations

Ingrid A. Beck, Sheila Styrchak, Samantha Hardy, Jackson Wallner, Ross Milne +6 more

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00737-23

N/A

0DataRank · unranked

16 citations

Adrie Bekker, Eric Decloedt, Jiajia Wang, Gerhard Theron, Mark F. Cotton +16 more

Brief Report: Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003281

N/A

0DataRank · unranked

6 citations

Mina Nikanjam, Brookie M. Best, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey +1 more

Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy

Obstetrics and Gynecology Clinics of North America(2023)10.1016/j.ogc.2022.10.013

N/A

0DataRank · unranked

3 citations

Kimberly K. Scarsi, Mark Mirochnick, Kristina M. Brooks

Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum

Clinical Infectious Diseases(2024)10.1093/cid/ciae001

N/A

0DataRank · unranked

12 citations

Sean S. Brummel, Lauren Ziemba, Lameck Chinula, Katie McCarthy, Lee Fairlie +88 more

Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study

Journal of Antimicrobial Chemotherapy(2024)10.1093/jac/dkae259

N/A

0DataRank · unranked

1 citations

Edmund V. Capparelli, Mark Mirochnick, Diana F. Clarke, Mark F. Cotton, Roger Shapiro +9 more

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

The Pediatric Infectious Disease Journal(2024)10.1097/inf.0000000000004243

N/A

0DataRank · unranked

0 citations

Jincheng Yang, Jiajia Wang, Mark F. Cotton, Mae Cababasay, Lubbe Wiesner +9 more

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2048

N/A

0DataRank · unranked

49 citations

Adeniyi Olagunju, Jeremiah D. Momper, Martina Penazzato, Elaine J. Abrams, Brookie M. Best +12 more

Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf504

N/A

0DataRank · unranked

3 citations

Flynn McMorrow, Kristina M. Brooks, Mauricio Pinilla, Lee Fairlie, James S. Ngocho +38 more

Darunavir Pharmacokinetics With an Increased Dose During Pregnancy

JAIDS Journal of Acquired Immune Deficiency Syndromes(2020)10.1097/qai.0000000000002261

N/A

0DataRank · unranked

20 citations

Alice Stek, Jiajia Wang, Régis Kreitchmann, David E. Shapiro, Elizabeth Smith +6 more

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.02260-19

N/A

0DataRank · unranked

11 citations

Jiajia Wang, Khadija Amin, David E. Shapiro, Alice Stek, Elizabeth Smith +42 more

Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

UNC Libraries(2020)10.17615/dqr7-0g70

N/A

0DataRank · unranked

0 citations

Patrick Jean‐Philippe, Lynne Mofenson, James F. Rooney, Jack Rodman, Edwin Thorpe +13 more

Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study

The Lancet HIV(2021)10.1016/s2352-3018(21)00266-6

N/A

0DataRank · unranked

12 citations

Edmund V Capparelli, Avy Violari, Mark F Cotton, Mae Cababasay, Jiajia Wang +12 more

Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development

Frontiers in Pediatrics(2021)10.3389/fped.2021.721059

N/A

0DataRank · unranked

11 citations

Mary Gockenbach, Manuela Grimstein, Hari Cheryl Sachs, Mark Mirochnick, Kimberly Struble +8 more

Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens

Contraception(2021)10.1016/j.contraception.2021.08.006

N/A

0DataRank · unranked

5 citations

Alice Stek, Brookie M. Best, Edmund V. Capparelli, Jiajia Wang, David E. Shapiro +4 more

Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents

Clinical Infectious Diseases(2022)10.1093/cid/ciac754

N/A

0DataRank · unranked

29 citations

Edmund V. Capparelli, Theodore Ruel, Mark Mirochnick, Elaine J. Abrams

Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure

Clinical Infectious Diseases(2022)10.1093/cid/ciac001

N/A

0DataRank · unranked

12 citations

Adrie Bekker, Belén P. Solans, Mark F. Cotton, Mark Mirochnick, Avy Violari +8 more